Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-03-15

FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved a supplemental application to add Aleve GelCaps containing naproxen sodium, expanding the approval to include a new dosage form for this drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALEVE GELCAPS (NAPROXEN SODIUM)

Snippet

SUPPL AP for ALEVE GELCAPS (NAPROXEN SODIUM)